Time New York: Sat 03 Dec 18:53 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Why Genesis Healthcare (GEN) Could Be Positioned for a Surge

Zacks

Genesis Healthcare, Inc. GEN is a provider of long-term care, assisted/senior living and rehabilitation therapy that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on GEN’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Genesis Healthcare could be a solid choice for investors.

Current Quarter Estimates for GEN

In the past 30 days, 1 estimate has gone higher for Genesis Healthcare while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 29 cents a share 30 days ago, to a loss of 7 cents per share today, a move of 75.9%.


Current Year Estimates for GEN

Meanwhile, Genesis Healthcare’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of $1.29 per share 30 days ago to a loss of 74 per share today, an increase of 42.6%.

GENESIS HLTHCR Price and Consensus

GENESIS HLTHCR Price and Consensus | GENESIS HLTHCR Quote

Bottom Line

The stock has also started to move higher lately, adding 31.8% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 ""Strong Buy"" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 ""Strong Sells"" and other private research. See these stocks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.